Literature DB >> 8390003

Hypothalamo-pituitary-adrenal axis in uraemia: evidence for primary adrenal dysfunction?

A C Grant1, R S Rodger, R Mitchell, S Gibson, A White, W R Robertson.   

Abstract

To study hypothalamo-pituitary-adrenal axis disturbances in chronic renal failure, we administered corticotrophin-releasing hormone to patients undergoing haemodialysis and CAPD and to normal controls. Cortisol, ACTH, and ACTH precursors were measured before and after corticotrophin-releasing hormone using sensitive and specific two-site assays. Baseline ACTH and cortisol were similar in all groups. Peak values occurred at 30 min (ACTH) and between 30 and 60 min (cortisol). The cortisol (but not the ACTH) responses were significantly reduced in patients with renal failure (P < 0.05). ACTH precursors did not change from baseline following corticotrophin-releasing hormone but were significantly elevated in patients with renal failure compared to controls (P < 0.01). The reduced cortisol response to corticotrophin-releasing hormone may reflect a primary defect of adrenal function in renal failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390003

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Association between adrenal function and dialysis vintage in hemodialysis patients.

Authors:  Yukitoshi Sakao; Naro Ohashi; Taichi Sato; Sayaka Ishigaki; Shinsuke Isobe; Tomoyuki Fujikura; Akihiko Kato; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2022-05-21       Impact factor: 2.617

2.  The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Authors:  Y Oguz; C Oktenli; M Ozata; T Ozgurtas; Y Sanisoglu; M Yenicesu; A Vural; F Bulucu; I H Kocar
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 3.  Adrenal function testing in dialysis patients - a review of the literature.

Authors:  Lara Brotzer; Manuela Nickler; Min Jeong Kim; Beat Mueller; Claudine A Blum
Journal:  BMC Nephrol       Date:  2021-11-01       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.